Search for: "Companies A, B, and C" Results 8221 - 8240 of 12,883
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2022, 12:04 pm by Zak Gowen
  The branded company can then sue the generic company for patent infringement, thereby resolving the patent dispute before entry and before the generic company would incur damages that would otherwise be a disincentive to enter the market. [read post]
15 Feb 2013, 5:11 am by Ed. Microjuris.com Puerto Rico
La primera charla se llevó a cabo el 29 de enero, a cargo de Theodore B. [read post]
13 Jun 2012, 10:31 am by FDABlog HPM
Reg. 39,588), and states: (c) Failure to take action. (1) An applicant agrees to extend the review period under section 505(c)(1) or (j)(5)(A) of the act until it takes any of the actions listed in paragraph (b) of this section [(i.e., resubmission, withdrawal, or request opportunity for hearing)]. [read post]
5 Jun 2020, 2:27 pm by Eugene Volokh
" The court noted that "[b]ecause such laws vary widely from state to state, no litigant will know if he is entitled to immunity for a state claim until a court decides the legal issue. [read post]
19 Oct 2011, 3:30 am by Marie Louise
  Highlights this week included: EU: No more patents for cells derived from human embryos in EU – ECJ issues final verdict in Brüstle v Greenpeace (C? [read post]
3 Dec 2011, 9:56 am by Law Lady
., Appellee. 1st District.Administrative law -- Agency for Health Care Administration -- Revocation of assisted living facility licenses, denial of licensure renewal applications, and imposition of administrative fines -- Claims against licensee were not proven where only evidence to support claims was uncorroborated hearsay -- Claim that licensee operated another assisted living facility without obtaining a valid license or qualifying for a license exemption was not proven where evidence was… [read post]
13 Feb 2012, 3:40 pm by admin
To assess the effects of the alleged practises on Swiss clients and companies is one of the aims of the investigation. [read post]
24 Jan 2014, 12:57 am by Kevin LaCroix
Executives should be encouraged to take prudent risks for the benefit of the company and its constituents, and should not be stymied by the fear of personal liability if a decision ultimately harms the company. [read post]